目的 通过分析鞍山市2015-2018年疑似预防接种异常反应(AEFI)的发生特征, 评价鞍山市儿童免疫规划疫苗的安全性。方法 通过AEFI信息管理系统收集2015-2018年鞍山市AEFI个案数据, 采用描述性流行病学方法进行分析。结果 鞍山市2015-2018年累计报告儿童免疫规划疫苗AEFI病例863例, 其中2015年报告199例、2016年报告231例、2017年报告170例、2018年报告263例。总报告发生率为42.53/105, 其中一般反应796例, 占92.24%;异常反应39例, 占4.52%;偶合症26例, 占3.01%;心因性反应1例, 占0.12%;待定1例, 占0.12%。0~1岁年龄段共报告649例, 占总报告数的75.20%。报告数和发生率最高的疫苗为吸附无细胞百白破联合疫苗, 报告336例(93.19/10万)。结论 鞍山市AEFI监测灵敏度较高, 儿童免疫规划疫苗安全性较好。
Abstract
Objective To analyze the characteristics of suspected adverse event following immunization (AEFI) in Anshan City during 2015-2018, so as to evaluate the safety of national immunization program vaccines. Methods The AEFI case data of Anshan City during 2015-2018, collected by the AEFI information management system were analyzed by descriptive epidemiological method. Results A total of 863 AEFI cases caused by immunization program vaccines for children were reported in Anshan during 2015-2018, with 199 cases in 2015, 231 cases in 2016, 170 cases in 2017 and 263 cases in 2018.The overall reported incidence was 42.53/105.Among all the reported cases, 796(92.24%) cases were common adverse reactions, 39(4.52%) cases were rare adverse reactions, 26(3.01%) cases were coincidental events, and 1(0.12%) case was psychogenic reaction, 1(0.12%) case was undetermined.A total of 649(75.20%) cases occurred among children under one year old.The vaccine with the highest reported number and incidence of AEFI was the DTaP vaccine, reported by 336 cases (93.19/105). Conclusion AEFI monitoring in Anshan is of high sensitivity, and national immunization program vaccines for children are highly safe.
关键词
疑似预防接种异常反应 /
免疫规划疫苗 /
监测
Key words
suspected adverse events following immunization /
national immunization program vaccine /
monitoring
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Dub E, Laberge C, Guay M, et al.Vaccine hestitancy[J].Hum Vacc Immunother, 2013, 9(8):1763-1773.
[2] 陈艳军, 徐绍和, 曲帅征, 等.鞍山市2009～2013年疑似预防接种异常反应监测分析[J].中国公共卫生, 2015, 31(2):252-254.
[3] 全国疑似预防接种异常反应监测方案[J].中国疫苗和免疫, 2011, 17(1):72-81.
[4] 许涤沙, 李克莉, 武文娣, 等.中国2016年疑似预防接种异常反应监测数据分析[J].中国疫苗和免疫, 2018, 24(3):299-309, 322.
[5] 唐文钊, 朱秀兰, 王莹.2011～2018年惠州市疑似预防接种异常反应监测数据分析[J].公共卫生与预防医学, 2019, 30(2):112-115.
[6] 叶家楷, 李克莉, 许涤沙, 等.中国2015年疑似预防接种异常反应监测分析[J].中国疫苗和免疫, 2017, 23(5):481-492, 511.
[7] 韩一楠, 杨月, 林茜.大连市2011～2016年疑似预防接种异常反应监测分析[J].中国生物制品学杂志, 2018, 31(2):170-176.
[8] 邱德山, 刘海田, 王怡.2013-2016年潍坊市疑似预防接种异常反应监测分析[J].现代预防医学, 2017, 44(19):3631-3635.
[9] 刘玉霞, 刘玉琳.不同剂次百白破疫苗接种后发生疑似预防接种反应的分析[J].河北医药, 2015, 37(23):3631-3632.
[10] 陈敏, 梁亚琼, 徐鹭, 等.2013～2016年南京市疑似预防接种异常反应监测分析[J].现代预防医学, 2017, 44(23):4284-4288.
[11] 高波, 孙灵英, 袁月荣, 等.浙江省宁波市江东区2010～2015年疑似预防接种异常反应监测分析[J].中国疫苗和免疫, 2017, 23(3):322-326.
[12] 陈翔, 樊芸, 刘鹏, 等.2017-2018年成都市龙泉驿区疑似预防接种异常反应监测分析[J].预防医学情报杂志, 2020, 36(2):234-239.
[13] 谢广钟, 刁连东, 王树巧, 等.预防接种的反应和处理[M].3版.上海:上海科学技术出版社, 2009:431-459.
[14] Shorvon S, Berg A.Pertussis vaccination and epilepsy - an erratic history, new research and the mismatch between science and social policy[J].Epilepsia, 2008, 49(2):219-225
[15] 张梦娜, 邹丽萍.儿童癫痫与接种常规疫苗异常反应研究进展[J].中华实用儿科临床杂志, 2017, 32(8):634-636.
PDF(702 KB)
